ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, according to the FDA Fast Track process they could have a rolling review.

Rolling Review, which means that a drug company can submit completed sections of its Biologic License Application (BLA) or New Drug Application (NDA) for review by FDA, rather than waiting until every section of the NDA is completed before the entire application can be reviewed. BLA or NDA review usually does not begin until the drug company has submitted the entire application to the FDA

Fast track.

I imagine they can file later this year and provide the final readout during the review period.